|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0016017,
umls-concept:C0037369,
umls-concept:C0040018,
umls-concept:C0042401,
umls-concept:C0332307,
umls-concept:C0337667,
umls-concept:C0684336,
umls-concept:C0871261,
umls-concept:C1257901,
umls-concept:C1515655,
umls-concept:C1704632,
umls-concept:C1706089,
umls-concept:C1706817,
umls-concept:C1801960,
umls-concept:C2911692
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2008-6-27
|
|
pubmed:abstractText |
We sought to test the hypothesis that cigarette smoking adversely alters protease-activated receptor type 1 (PAR-1)-mediated vascular effects in vivo in humans.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Bradykinin,
http://linkedlifedata.com/resource/pubmed/chemical/Nitroprusside,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/Plasminogen Activator Inhibitor 1,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, PAR-1,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Thrombin,
http://linkedlifedata.com/resource/pubmed/chemical/Tissue Plasminogen Activator,
http://linkedlifedata.com/resource/pubmed/chemical/Vasodilator Agents,
http://linkedlifedata.com/resource/pubmed/chemical/thrombin receptor peptide (42-47)
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1558-3597
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
52
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
33-9
|
|
pubmed:meshHeading |
pubmed-meshheading:18582632-Adult,
pubmed-meshheading:18582632-Biological Markers,
pubmed-meshheading:18582632-Bradykinin,
pubmed-meshheading:18582632-Dose-Response Relationship, Drug,
pubmed-meshheading:18582632-Endothelium, Vascular,
pubmed-meshheading:18582632-Female,
pubmed-meshheading:18582632-Fibrinolysis,
pubmed-meshheading:18582632-Forearm,
pubmed-meshheading:18582632-Hemodynamics,
pubmed-meshheading:18582632-Humans,
pubmed-meshheading:18582632-Male,
pubmed-meshheading:18582632-Middle Aged,
pubmed-meshheading:18582632-Nitroprusside,
pubmed-meshheading:18582632-Peptide Fragments,
pubmed-meshheading:18582632-Plasminogen Activator Inhibitor 1,
pubmed-meshheading:18582632-Plethysmography,
pubmed-meshheading:18582632-Receptor, PAR-1,
pubmed-meshheading:18582632-Receptors, Thrombin,
pubmed-meshheading:18582632-Research Design,
pubmed-meshheading:18582632-Risk Factors,
pubmed-meshheading:18582632-Smoking,
pubmed-meshheading:18582632-Thrombosis,
pubmed-meshheading:18582632-Tissue Plasminogen Activator,
pubmed-meshheading:18582632-Vasodilation,
pubmed-meshheading:18582632-Vasodilator Agents
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Marked impairment of protease-activated receptor type 1-mediated vasodilation and fibrinolysis in cigarette smokers: smoking, thrombin, and vascular responses in vivo.
|
|
pubmed:affiliation |
Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom. ninian.lang@ed.ac.uk
|
|
pubmed:publicationType |
Journal Article
|
